PARK15/FBXO7 is dispensable for PINK1/Parkin mitophagy in iNeurons and HeLa cell systems

被引:9
|
作者
Kraus, Felix [1 ]
Goodall, Ellen A. [1 ,2 ]
Smith, Ian R. [1 ]
Jiang, Yizhi [1 ]
Paoli, Julia C. [1 ]
Adolf, Frank [2 ,3 ]
Zhang, Jiuchun [1 ]
Paulo, Joao A. [1 ]
Schulman, Brenda A. [2 ,3 ]
Harper, J. Wade [1 ,2 ]
机构
[1] Harvard Med Sch, Blavatnik Inst, Dept Cell Biol, Boston, MA 02115 USA
[2] Aligning Sci Parkinsons ASAP Collaborat Res Networ, Chevy Chase, MD 20815 USA
[3] Max Planck Inst Biochem, Dept Mol Machines & Signaling, Martinsried, Germany
关键词
FBXO7; iNeurons; mitophagy; proteomics; ubiquitin ligase; FALSE DISCOVERY RATE; PROTEASOME ACTIVITY; UBIQUITIN CHAIN; QUALITY-CONTROL; PARKIN; PINK1; FBXO7; PHOSPHORYLATION; MECHANISM; PLATFORM;
D O I
10.15252/embr.202256399
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The protein kinase PINK1 and ubiquitin ligase Parkin promote removal of damaged mitochondria via a feed-forward mechanism involving ubiquitin (Ub) phosphorylation (pUb), Parkin activation, and ubiquitylation of mitochondrial outer membrane proteins to support the recruitment of mitophagy receptors. The ubiquitin ligase substrate receptor FBXO7/PARK15 is mutated in an early-onset parkinsonian-pyramidal syndrome. Previous studies have proposed a role for FBXO7 in promoting Parkin-dependent mitophagy. Here, we systematically examine the involvement of FBXO7 in depolarization and (UPR)-U-mt-dependent mitophagy in the well-established HeLa and induced-neurons cell systems. We find that FBXO7(-/-) cells have no demonstrable defect in: (i) kinetics of pUb accumulation, (ii) pUb puncta on mitochondria by super-resolution imaging, (iii) recruitment of Parkin and autophagy machinery to damaged mitochondria, (iv) mitophagic flux, and (v) mitochondrial clearance as quantified by global proteomics. Moreover, global proteomics of neurogenesis in the absence of FBXO7 reveals no obvious alterations in mitochondria or other organelles. These results argue against a general role for FBXO7 in Parkin-dependent mitophagy and point to the need for additional studies to define how FBXO7 mutations promote parkinsonian-pyramidal syndrome.
引用
收藏
页数:26
相关论文
共 50 条
  • [41] PINK1/Parkin-mediated mitophagy promotes apelin-13-induced vascular smooth muscle cell proliferation by AMPKα and exacerbates atherosclerotic lesions
    He, Lu
    Zhou, Qionglin
    Huang, Zheng
    Xu, Jin
    Zhou, Hong
    Lv, Deguan
    Lu, Liqun
    Huang, Shifang
    Tang, Mingzhu
    Zhong, Jiuchang
    Chen, Jian-xiong
    Luo, Xuling
    Li, Lanfang
    Chen, Linxi
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (06) : 8668 - 8682
  • [42] TOMM7 Alleviates Diabetic Kidney Disease by Regulating PINK1/Parkin-Mediated Mitophagy via Intracellular Redistribution of PLA2G6
    Wang Yihui
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [43] Human umbilical cord mesenchymal stem cell-derived exosome suppresses programmed cell death in traumatic brain injury via PINK1/Parkin-mediated mitophagy
    Zhang, Li
    Lin, Yixing
    Bai, Wanshan
    Sun, Lean
    Tian, Mi
    CNS NEUROSCIENCE & THERAPEUTICS, 2023, 29 (08) : 2236 - 2258
  • [44] Silibinin alleviates ferroptosis of rat islet β cell INS-1 induced by the treatment with palmitic acid and high glucose through enhancing PINK1/parkin-mediated mitophagy
    Du, Qingqing
    Wu, Xiaoyun
    Ma, Kai
    Liu, Weiwei
    Liu, Panwen
    Hayashi, Toshihiko
    Mizuno, Kazunori
    Hattori, Shunji
    Fujisaki, Hitomi
    Ikejima, Takashi
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2023, 743
  • [45] Systematic Review and UK-Based Study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease
    Kilarski, Laura L.
    Pearson, Justin P.
    Newsway, Victoria
    Majounie, Elisa
    Knipe, M. Duleeka W.
    Misbahuddin, Anjum
    Chinnery, Patrick F.
    Burn, David J.
    Clarke, Carl E.
    Marion, Marie-Helene
    Lewthwaite, Alistair J.
    Nicholl, David J.
    Wood, Nicholas W.
    Morrison, Karen E.
    Williams-Gray, Caroline H.
    Evans, Jonathan R.
    Sawcer, Stephen J.
    Barker, Roger A.
    Wickremaratchi, Mirdhu M.
    Ben-Shlomo, Yoav
    Williams, Nigel M.
    Morris, Huw R.
    MOVEMENT DISORDERS, 2012, 27 (12) : 1522 - 1529
  • [46] Mitophagy-associated genes PINK1 and PARK2 are independent prognostic markers of survival in papillary renal cell carcinoma and associated with aggressive tumor behavior
    Simon, Adrian Georg
    Tolkach, Yuri
    Esser, Laura Kristin
    Ellinger, Joerg
    Stoehr, Christine
    Ritter, Manuel
    Wach, Sven
    Taubert, Helge
    Stephan, Carsten
    Hartmann, Arndt
    Kristiansen, Glen
    Branchi, Vittorio
    Toma, Marieta Ioana
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [47] Mitophagy-associated genes PINK1 and PARK2 are independent prognostic markers of survival in papillary renal cell carcinoma and associated with aggressive tumor behavior
    Adrian Georg Simon
    Yuri Tolkach
    Laura Kristin Esser
    Jörg Ellinger
    Christine Stöhr
    Manuel Ritter
    Sven Wach
    Helge Taubert
    Carsten Stephan
    Arndt Hartmann
    Glen Kristiansen
    Vittorio Branchi
    Marieta Ioana Toma
    Scientific Reports, 10
  • [48] Zinc oxide nanoparticles induce toxicity in diffuse large B-cell lymphoma cell line U2932 via activating PINK1/Parkin-mediated mitophagy.
    Li, Zonghong
    Yin, Xuewei
    Lyu, Chunyi
    Wang, Teng
    Wang, Wenhao
    Zhang, Jiachen
    Wang, Jinxin
    Wang, Zhenzhen
    Han, Chen
    Zhang, Ruixue
    Guo, Dadong
    Xu, Ruirong
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 164
  • [49] IRF1-mediated upregulation of PARP12 promotes cartilage degradation by inhibiting PINK1/Parkin dependent mitophagy through ISG15 attenuating ubiquitylation and SUMOylation of MFN1/2
    Deng, Zengfa
    Long, Dianbo
    Li, Changzhao
    Liu, Hailong
    Li, Wei
    Zhong, Yanlin
    Mo, Xiaolin
    Li, Ruiyun
    Yang, Zibo
    Kang, Yan
    Mao, Guping
    BONE RESEARCH, 2024, 12 (01)
  • [50] Resveratrol regulates PINK1/Parkin-mediated mitophagy via the lncRNA ZFAS1-miR-150-5p-PINK1 axis, and enhances the antitumor activity of paclitaxel against non-small cell lung cancer
    Kong, Fanhua
    Xie, Chuan
    Zhao, Xudong
    Zong, Xiang
    Bu, Lingguo
    Zhang, Bo
    Tian, Hui
    Ma, Shengjun
    TOXICOLOGY RESEARCH, 2022, 11 (06) : 962 - 974